ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Ability Inc (CE)

Ability Inc (CE) (ABILF)

0.0001
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.0001
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
750
Financial Volume
-
VWAP
-
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4000.00010.00010.00017000.0001CS
12000.00010.00011.0E-67508.68E-5CS
269.0E-59001.0E-50.00011.0E-633597.521E-5CS
529.9E-599001.0E-60.00011.0E-636328.087E-5CS
156-0.1999-99.950.20.21.0E-629340.00036835CS
260-0.1399-99.92857142860.140.91751.0E-676140.39111661CS

ABILF - Frequently Asked Questions (FAQ)

What is the current Ability (CE) share price?
The current share price of Ability (CE) is $ 0.0001
What is the 1 year trading range for Ability (CE) share price?
Ability (CE) has traded in the range of $ 0.000001 to $ 0.0001 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VGFCQVery Good Food Company Inc (CE)
$ 0.005
(499,900.00%)
259.63k
NTPLNetplex Group Inc (CE)
$ 0.0025
(249,900.00%)
400
BIRMFBiorem Inc (PK)
$ 1.70
(154,445.45%)
9.7k
OSKADAmpliPay Group Inc (PK)
$ 1.10
(52,280.95%)
204
ANGCFEon Lithium Corporation (PK)
$ 1.00
(28,471.43%)
100
TAYOTaylor Consulting Inc (CE)
$ 0.000001
(-99.83%)
1,000
RGFCReal Good Food Company Inc (CE)
$ 0.0001
(-99.80%)
915
BIMIBIMI International Medical Inc (CE)
$ 0.0001
(-99.67%)
1,000
COGDFCompass Gold Corporation (PK)
$ 0.0005
(-99.67%)
6.06k
BIOAFBioasis Technologies Inc (CE)
$ 0.000001
(-99.50%)
2.5k
AFFUAffluence Corp (PK)
$ 0.0002
(42.86%)
328.94M
GTCHGBT Technologies Inc (PK)
$ 0.00025
(-16.67%)
279.95M
PSWWPrincipal Solar Inc (PK)
$ 0.0005
(25.00%)
208.44M
HMBLHUMBL Inc (PK)
$ 0.0003
(20.00%)
173.92M
DPLSDarkPulse Inc (PK)
$ 0.0004
(14.29%)
135.91M

Discussion

View Full Feed
fuagf fuagf 11 minutes ago
As one who agrees yay for them all, as a retired teacher special kudos for the last:

https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/504303855_1035121872140905_2707895258088881484_n.jpg?_nc_cat=104&ccb=1-7&_nc_sid=833d8c&_nc_ohc=9nX-zx1MrM4Q7kNvwH_P3Zn&_nc_oc=Adk-srxeQcezVhzQ5W8cL
Snd101 Snd101 12 minutes ago
If getting this before the eyes of AMRN legal team has 1% chance of making it to the court, I believe the best route would be via one of Amarin employees. If anybody knows an Amarin employee. Stuffs coming from external email hardly gets any attention.
AMRN
sam1933 sam1933 13 minutes ago
Canada has approved the first spot XRP ETF. Purpose Investments received regulatory approval from the Ontario Securities Commission (OSC) to launch the Purpose XRP ETF, which will begin trading on the Toronto Stock Exchange (TSX) under the ticker XRPP on June 18, 2025
XRPUSD
PegnVA PegnVA 15 minutes ago
Anything for attention.
jondoeuk jondoeuk 16 minutes ago
I've heard that an MD Anderson team is developing an off-the-shelf IL-21 armoured CAR-NK cell therapy that will target EGFR and IL13Ra2 https://www.cell.com/cancer-cell/abstract/S1535-6108(24)00272-1

They are also testing another off-the-shelf NK cell therapy with containing deleted o
GILD
fuagf fuagf 19 minutes ago
dbergh, First many immunodeficient people wear masks to protect their lives, that first interviewer is as ignorant as you.

The 2nd again exhibits the ignorance of the one you see as smart:

Type of hormone therapy may determine whether trans men continue to menstruate
Bull_Dolphin Bull_Dolphin 24 minutes ago
Matt Gaetz on involvement with Israel in Iran:

https://worldnews.whatfinger.com/2025/06/17/daaammmn-matt-gaetz-trump-and-iran-israel-hot-take-%f0%9f%94%a5%f0%9f%94%a5/
jttcomm jttcomm 29 minutes ago
Oh boy. You are the wit. So who is this toxic lender you speak of. No offense but it is difficult to believe the stories that go around and around.
NBRI
joeycav11 joeycav11 36 minutes ago
The amount of detail in this new program is extraordinary. You can sense the exuberance of the author.
The main takeaway is that dcvax will be the poster child of this new hugely exciting program.
There isn’t any other exciting drug on the horizon that could get people excited.That’s
NWBO
joeycav11 joeycav11 36 minutes ago
The amount of detail in this new program is extraordinary. You can sense the exuberance of the author.
The main takeaway is that dcvax will be the poster child of this new hugely exciting program.
There isn’t any other exciting drug on the horizon that could get people excited.That’s
NWBO
OzzieTrader OzzieTrader 37 minutes ago
45 million shares traded price 9.2c down 7%
DTREF
JohnKnowsIt JohnKnowsIt 52 minutes ago
Robert Hipple once wrote my opinion letter
WPFH
JohnKnowsIt JohnKnowsIt 53 minutes ago
Pretty incredible Indian river is still on the filings
WPFH
JohnKnowsIt JohnKnowsIt 55 minutes ago
Henry where are my shares? Time for some legal….
WPFH
JohnKnowsIt JohnKnowsIt 56 minutes ago
But no stocks go up in this space… it’s all about selling shares
WPFH
Pickme2 Pickme2 57 minutes ago
Keep adding...at this rate, there will be billions available and you'll be rich..
ATMH
JohnKnowsIt JohnKnowsIt 57 minutes ago
Rich but not a billionaire
WPFH
mdb1 mdb1 59 minutes ago
Futures are UP. I was 100% sure they would be way down tomorrow. What? Who knew.
MP
Pickme2 Pickme2 1 hour ago
Just be patient...you've waited 5 years ...when there was tens of Millions... Now there's hundreds of millions!! Your time will come
ATMH
PickStocks PickStocks 1 hour ago
No one...
COOP
PickStocks PickStocks 1 hour ago
You may claim 41.6.....but who enforces it.....no one...you could be waiting decades thinking JPM owes you something....you may have received it from the GSA.....but the GSA was between WMI, JPM and the FDIC and JPM came away with 600+ million.....escrows were not part of it.....would like for you t
JPM
Jballer134 Jballer134 1 hour ago
BETTER OFF DONATING THE 100$ TO A SOUP KITCHEN
CLNV
jondoeuk jondoeuk 1 hour ago
It will be interesting to see GILD's KITE-753 clinical data. The only difference between it (and KITE-363) is a reduced production time.

However, based on preclinical data, KITE-753 exhibited higher expression of both CARs and increased proportion of CCR7+/CD45RA+ T-cells* compared to
LYEL
jondoeuk jondoeuk 1 hour ago
It will be interesting to see GILD's KITE-753 clinical data. The only difference between it (and KITE-363) is a reduced production time.

However, based on preclinical data, KITE-753 exhibited higher expression of both CARs and increased proportion of CCR7+/CD45RA+ T-cells* compared to
GILD
HyGro HyGro 1 hour ago
Ah, ha, ha. Then why didn't NWBO file with the FDA??? There's no material money in a UK approval. Only the U.S. delivers serious revenue and profitable pricing. If FDA considered the P3 trial legitimate, they would have encouraged NWBO to file, but.........nothing. Even if MHRA buys it, FD
NWBO

Your Recent History

Delayed Upgrade Clock